Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AG3340 with Mitoxantrone and Prednisone in Hormone-Refractory Prostate Cancer
NCT00003343Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 1998
- Primary completion
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prinomastat in prostate cancer (PCa), sponsored by Pfizer. Started Mar 1998; status: completed.
02
Drugs
prinomastat
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003343.